WGS – genedx holdings corp. - class a (US:NASDAQ)
Stock Stats
News
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at BTIG Research from $11.00 to $15.00. They now have a "buy" rating on the stock.
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $6.00 to $11.00. They now have a "neutral" rating on the stock.
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
Dr. Marra Francis Joins Genece Health as Chief Medical Officer [Yahoo! Finance]
Form 4 GeneDx Holdings Corp. For: Mar 16 Filed by: Stueland Katherine
Form 4 GeneDx Holdings Corp. For: Mar 16 Filed by: Saad Kareem
Form 4 GeneDx Holdings Corp. For: Mar 16 Filed by: Feeley Kevin
Form 4 GeneDx Holdings Corp. For: Mar 12 Filed by: Feeley Kevin
Form 4 GeneDx Holdings Corp. For: Mar 12 Filed by: Stueland Katherine
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.